Related Experiment Video
Updated: Aug 22, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Platelet activation, inflammatory mediators and hypercholesterolemia
Patrizia Ferroni1, Stefania Basili, Giovanni Davi
1Dept. of Experimental Medicine & Pathology, University of Rome, La Sapienza, Italy.
Insights
High cholesterol (hypercholesterolemia) drives inflammation and platelet activation, contributing to atherosclerosis. Understanding this interplay may reveal new therapeutic targets for cardiovascular disease.
Area of Science:
- Cardiovascular Science
- Inflammation Research
- Hematology
Background:
- Atherosclerosis is linked to altered cholesterol metabolism and inflammation.
- Inflammatory markers, cytokines, and adhesion molecules are associated with hypercholesterolemia and atherosclerosis.
- Platelets play a significant role in the inflammatory response within atherosclerotic lesions.
Purpose of the Study:
- To review the interplay between hypercholesterolemia, inflammation, and platelet activation in atherosclerosis.
- To explore the pathophysiological implications of platelet activation in atherosclerotic plaque development.
- To discuss the impact of lipid-lowering treatments on these processes.
Main Methods:
- Literature review synthesizing current understanding of hypercholesterolemia, inflammation, and platelet function.
- Analysis of research on inflammatory mediators released by platelets.
- Examination of studies on the effects of lipid-lowering therapies.
Main Results:
- Hypercholesterolemia promotes inflammation involving artery wall and circulating cells, notably platelets.
- Activated platelets synthesize and release pro-inflammatory cytokines and chemokines, contributing to vascular injury.
- Platelet activation and hemostatic imbalance are implicated in atherosclerotic plaque progression.
Conclusions:
- Platelets have a critical, previously unrecognized role in atherosclerosis pathogenesis through inflammatory actions.
- Targeting platelet activation and inflammation may offer novel therapeutic strategies for atherosclerosis.
- Lipid-lowering treatments may influence these inflammatory and platelet-related phenomena.
Abstract:
Atherogenic cofactors, such as altered cholesterol metabolism, may impact locally on inflammatory responses in atherosclerotic lesions. Blood levels of inflammatory markers (e.g., C-reactive protein, fibrinogen) have been associated with hypercholesterolemia and with overt atherothrombotic disorders. More recently. cytokines (e.g., interleukin-6, interleukin-1beta) and soluble adhesion molecules (e.g., selectins, intercellular adhesion molecule-1, vascular cell adhesion molecule-1) have been associated with both hypercholesterolemia and atherosclerotic disease, suggesting their use as potential therapeutic targets for the non-specific "anti-inflammatory" treatment of atherosclerosis. The inflammatory response associated with hypercholesterolemia involves not only the intrinsic cells of the artery wall. but also circulating cells. Platelets participate in this disease process through the release of a wide variety of biologically active substances. An imbalance of the hemostatic system and persistent in vivo platelet activation can be observed in hypercholesterolemia and may have pathophysiological implications in the development and progression of atherosclerotic plaques. Recent findings on the inflammatory actions of platelets have established the potential for a previously unrecognized biologic role for platelets in inflammation and vascular injury, and have opened new perspectives in the comprehension of the pathogenetic mechanism(s) of atherosclerosis. Stimulated platelets actively synthesize proinflammatory cytokines (e.g., CD40L, IL-1beta) and are able to release chemokines (i.e., platelet factor-4, RANTES) which have been all involved in the inflammatory process associated with hypercholesterolemia. This review will summarize the present understanding of the interplay between hypercholesterolemia, inflammation and platelet activation in the development and progression of atherosclerosis, and we also discuss the effects of lipid-lowering treatment on these phenomena.
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Inflammation
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Cholesterol: Significance and Regulation
Considering cholesterol and...